LGB female Veterans’ experience of military service during the 'gay ban': a qualitative study

Abstract: Introduction: Until 2000, the UK Armed Forces implemented a 'gay ban' that led to the investigation and discharge of thousands of lesbian, gay, and bisexual (LGB) veterans. Yet, the experiences of those who served during the ban remain unknown. According to the minority stress model, individuals may face specific stressors related to both their gender and sexual minority status. Thus, the present study investigated the military experiences of female veterans who identify as LGB and who served during the ban.MethodsFemale LGB veterans (N = 10) were recruited from a larger cohort of female veterans who previously took part in a survey with a UK national veteran mental health charity. Participants were interviewed online using MS Teams between March and May 2022. A semi-structured interview Method was employed to explore Participants’ experiences of being LGB within the military as well as perceived differential treatment. Thematic qualitative analysis was used to identify key themes.ResultsThree overarching and seven subthemes were identified, reflecting the risk of being found out, the experience of negative treatment, and possible buffering factors.ConclusionsFemale LGB veterans who served under the 'gay ban' faced negative experiences, including fear and distress, sexism, and interpersonal and institutional discrimination related to their (perceived) sexual orientation. In addition to experiencing negative treatment during service similar to non-LGB female veterans, LGB female veterans may face an elevated risk of being targeted and additionally experience sexual orientation discrimination. Findings of the current study are in line with the minority stress model.Policy ImplicationsThe current Findings correspond with US evidence of ongoing negative treatment of LGB serving personnel. Together, this should encourage further investigation of ongoing negative treatment of LGB females within the UK Armed Forces, adaptations of veteran services to address unmet needs of female LGB veterans, and appropriate training to combat negative differential treatment of LGB female serving personnel. (PsycInfo Database Record (c) 2023 APA, all rights reserved)

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.